Ekso Bionics Holdings, Inc. (NASDAQ:EKSO – Get Free Report) shares passed above its 50 day moving average during trading on Monday following a stronger than expected earnings report. The stock has a 50 day moving average of $0.43 and traded as high as $0.50. Ekso Bionics shares last traded at $0.48, with a volume of 198,546 shares traded.
The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.01). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The company had revenue of $3.38 million for the quarter, compared to the consensus estimate of $4.62 million.
Wall Street Analyst Weigh In
A number of research firms have commented on EKSO. StockNews.com initiated coverage on shares of Ekso Bionics in a research note on Tuesday. They set a “hold” rating for the company. Lake Street Capital reduced their price target on shares of Ekso Bionics from $2.00 to $1.00 and set a “buy” rating for the company in a research report on Tuesday, March 4th. Finally, HC Wainwright lowered their price objective on shares of Ekso Bionics from $9.00 to $4.00 and set a “buy” rating on the stock in a research report on Tuesday.
Ekso Bionics Trading Down 9.1 %
The company has a 50 day simple moving average of $0.43 and a two-hundred day simple moving average of $0.60. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81. The company has a market cap of $12.56 million, a PE ratio of -0.67 and a beta of 1.09.
About Ekso Bionics
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Recommended Stories
- Five stocks we like better than Ekso Bionics
- How to Invest in Insurance Companies: A Guide
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- The Top-Ranked Insider Buys From April by Market Cap
- Insider Trading – What You Need to Know
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.
